查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930140

全球凝血因子市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析、未來預測（2026-2034）

Coagulation Factors Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 請詢問到貨日

價格

凝血因子市場成長驅動因子

全球凝血因子市場正經歷強勁成長，這主要得益於出血性疾病的增加、血漿衍生療法的進步以及主要市場參與者研發活動的擴大。根據 Fortune Business Insights 預測，該市場規模預計在 2025 年達到 68.9 億美元，並在 2026 年成長至 74.3 億美元。到 2034 年，該市場預計將達到 146.1 億美元，2026 年至 2034 年的複合年增長率 (CAGR) 為 8.81%。

預計到 2025 年，北美將佔市場主導地位，市佔率高達 58.17%，這得益於其強大的血漿採集基礎設施和先進療法的廣泛應用。

市場驅動因素

出血性疾病發生率上升

遺傳性出血性疾病（例如血友病A、血友病B和血管性血友病）盛行率的上升是市場成長的關鍵驅動因素。根據美國疾病管制與預防中心 (CDC) 統計，美國約有33,000名男性患有血友病，而血管性血友病影響約1%的人口。患者數量的增加顯著推動了對血漿衍生凝血因子濃縮物的需求。

創傷與事故發生率上升

全球事故和創傷病例的增加也促進了市場擴張。例如，根據印度公路運輸和公路部的一份報告，2022年印度將發生超過461,312起道路交通事故，這將促使急診和重症監護環境中對凝血因子的需求增加。

市場限制因子

嚴格的監理架構

由於對血漿採集、處理和分銷的嚴格要求，凝血因子市場面臨挑戰。美國食品藥物管理局 (FDA) 等監管機構根據 "公共衛生服務法" 和 "聯邦食品、藥品和化妝品法" 強制要求嚴格遵守相關規定，這可能會延遲審批並使製造商的運作複雜化。

市場機會

研發投入的增加

研發投入的增加正在創造新的成長機會。血漿分離設施的擴建和下一代療法的開發正在增強市場前景。 2022年12月，CSL Behring在澳洲開設了一家新的血漿分離工廠，以支持血友病和免疫系統疾病的治療，鞏固了該市場的長期成長潛力。

市場趨勢

創新長效療法的推出

長效凝血因子、先進的血漿分離技術以及標靶給藥系統的推出是關鍵的市場趨勢。此外，人工智慧 (AI) 和物聯網 (IoT) 技術的整合正在提高營運效率、供應鏈管理和患者參與度，從而促進市場擴張。

市場挑戰

高昂的初始投資和治療成本

血漿衍生產品生產設施需要大量資金，複雜的加工技術仍然是一項重大挑戰。部分地區有限的保險覆蓋範圍和高昂的治療成本阻礙了其普及，尤其是在新興市場，影響了整體市場滲透率。

細分市場分析

依類型劃分，VIII因子細分市場佔最大市場佔有率，這主要得益於A型血友病的高發生率。根據美國血友病聯盟（2025年）統計，全球有超過110萬人患有A型血友病。

依應用領域劃分，血液學細分市場推動了市場成長，這主要歸功於止血技術的進步以及血液相關疾病發病率的上升。

依終端使用者劃分，醫院和診所佔了大部分市場佔有率，這主要得益於患者入院人數的增加以及醫療服務提供者與製造商之間的合作。

區域分析

預計到2025年，北美地區的市場收入將達到40.1億美元，主要得益於血漿採集活動的增加和強有力的監管支持。

歐洲佔第二大市場佔有率，主要得益於血漿分離設施的擴張和策略性舉措。聯盟。

由於產能擴張和價格合理的血漿療法，預計亞太地區在預測期內將實現強勁增長。

由於醫療基礎設施的改善和公眾意識的提高，預計拉丁美洲、中東和非洲地區將保持穩定成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 出血性疾病的流行病學
  • 主要公司的新產品發布
  • 關鍵產業趨勢：併購、業務合作等
  • 關稅的影響市場

第五章 全球凝血因子市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • 凝血因子IX
    • 凝血因子VIII
    • 凝血酶原複合物濃縮物
    • 纖維蛋白原濃縮物
    • 其他
  • 市場分析、洞察與預測：依應用劃分
    • 免疫和神經系統疾病
    • 血液系統疾病
    • 重症監護
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院和診所
    • 臨床實驗室
    • 其他
  • 市場分析、洞察與預測：依區域
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美凝血因子市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲凝血因子市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲國家

第八章 亞太地區凝血因子市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲凝血因子市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲凝血因子市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（GCC）國家/地區
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • CSL
    • Takeda Pharmaceutical Company Limited
    • Kedrion S.p.A.
    • Octapharma AG
    • LFB
    • Bayer AG
Product Code: FBI112621

Growth Factors of coagulation factors Market

The global coagulation factors market is witnessing robust growth, driven by the increasing prevalence of bleeding disorders, advancements in plasma-derived therapies, and expanding research and development activities by key market players. According to Fortune Business Insights, the market was valued at USD 6.89 billion in 2025 and is projected to grow to USD 7.43 billion in 2026. By 2034, the market is expected to reach USD 14.61 billion, registering a compound annual growth rate (CAGR) of 8.81% from 2026 to 2034.

In 2025, North America dominated the market with a 58.17% share, supported by strong plasma collection infrastructure and advanced treatment availability.

Market Drivers

Rising Incidence of Bleeding Disorders

The growing prevalence of hereditary bleeding disorders such as hemophilia A, hemophilia B, and von Willebrand disease is a major factor driving market growth. According to the Centers for Disease Control & Prevention (CDC), approximately 33,000 males in the U.S. live with hemophilia, while von Willebrand disease affects nearly 1% of the population. The rising patient pool has significantly increased demand for plasma-derived coagulation products.

Increasing Trauma and Accident Cases

The rising number of accidents and trauma cases globally is further contributing to market expansion. For instance, India recorded over 461,312 road accidents in 2022, as reported by the Ministry of Road Transport and Highways, leading to increased demand for coagulation factors in emergency and critical care settings.

Market Restraints

Stringent Regulatory Frameworks

The coagulation factors market faces challenges due to stringent regulatory requirements governing plasma collection, processing, and distribution. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) enforce strict compliance under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act, which can delay approvals and increase operational complexity for manufacturers.

Market Opportunities

Growing Investments in Research and Development

Increasing investments in research and development are creating new growth opportunities. Expansion of plasma fractionation facilities and development of next-generation therapies are strengthening market prospects. In December 2022, CSL Behring opened a new plasma fractionation facility in Australia to support treatments for hemophilia and immune disorders, reinforcing long-term market growth potential.

Market Trends

Introduction of Innovative and Long-Acting Therapies

The launch of longer-acting coagulation factors, advanced plasma fractionation technologies, and targeted delivery systems is a key market trend. Additionally, integration of artificial intelligence (AI) and Internet of Things (IoT) technologies is improving operational efficiency, supply chain management, and patient engagement, contributing to market expansion.

Market Challenges

High Initial Investment and Treatment Costs

High capital requirements for plasma-derived manufacturing facilities and complex processing technologies remain a significant challenge. Limited reimbursement coverage in some regions and high therapy costs restrict broader adoption, particularly in emerging markets, thereby affecting overall market penetration.

Segmentation Analysis

By type, the Factor VIII segment held the largest market share, driven by the high prevalence of hemophilia A. According to the Hemophilia Federation of America (2025), more than 1.1 million individuals worldwide suffer from hemophilia A.

By application, the hematology segment dominated due to advancements in hemostasis technologies and rising cases of blood-related disorders.

By end user, hospitals and clinics accounted for the majority share, supported by higher patient admissions and collaboration between healthcare providers and manufacturers.

Regional Insights

North America generated USD 4.01 billion in revenue in 2025, driven by rising plasma collection activities and strong regulatory support.

Europe held the second-largest share due to expansion of plasma fractionation facilities and strategic partnerships.

Asia Pacific is projected to witness strong growth during the forecast period, supported by capacity expansion and affordable plasma-based therapies.

Latin America and the Middle East & Africa are expected to grow steadily with improving healthcare infrastructure and rising awareness.

Competitive Landscape

The market is moderately consolidated, with leading players such as CSL, Takeda Pharmaceutical Company, Kedrion S.p.A., and Octapharma AG focusing on capacity expansion, product innovation, and strategic collaborations. Continuous FDA approvals and new facility investments are strengthening their global market presence.

Conclusion

In conclusion, the global coagulation factors market is set for significant growth, expanding from USD 6.89 billion in 2025 to USD 14.61 billion by 2034. Rising prevalence of bleeding disorders, technological advancements, and increased investments in plasma-derived therapies are key growth drivers. Although regulatory complexities and high costs remain challenges, ongoing innovation, facility expansion, and strong demand across developed and emerging regions are expected to sustain long-term market growth during the forecast period.

Segmentation By Type

  • Factor IX
  • Factor VIII
  • Prothrombin Complex Concentrates
  • Fibrinogen Concentrates
  • Others

By Application

  • Immunology & Neurology
  • Hematology
  • Critical Care
  • Others

By End User

  • Hospitals & Clinics
  • Clinical Research Laboratories
  • Others

By Geography

  • North America (By Type, Application, End User, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End User, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Application, End User, and Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Latin America (By Type, Application, End User, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, End User, and Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Epidemiology of Bleeding Disorders
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments Such as Mergers, Acquisitions, and Collaborations
  • 4.4. Impact of Tariff on the Market

5. Global Coagulation Factors Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Factor IX
    • 5.1.2. Factor VIII
    • 5.1.3. Prothrombin Complex Concentrates
    • 5.1.4. Fibrinogen Concentrates
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Immunology & Neurology
    • 5.2.2. Hematology
    • 5.2.3. Critical Care
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & Clinics
    • 5.3.2. Clinical Research Laboratories
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Coagulation Factors Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Factor IX
    • 6.1.2. Factor VIII
    • 6.1.3. Prothrombin Complex Concentrates
    • 6.1.4. Fibrinogen Concentrates
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Immunology & Neurology
    • 6.2.2. Hematology
    • 6.2.3. Critical Care
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Clinical Research Laboratories
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Coagulation Factors Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Factor IX
    • 7.1.2. Factor VIII
    • 7.1.3. Prothrombin Complex Concentrates
    • 7.1.4. Fibrinogen Concentrates
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Immunology & Neurology
    • 7.2.2. Hematology
    • 7.2.3. Critical Care
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Clinical Research Laboratories
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Coagulation Factors Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Factor IX
    • 8.1.2. Factor VIII
    • 8.1.3. Prothrombin Complex Concentrates
    • 8.1.4. Fibrinogen Concentrates
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Immunology & Neurology
    • 8.2.2. Hematology
    • 8.2.3. Critical Care
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Clinical Research Laboratories
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Coagulation Factors Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Factor IX
    • 9.1.2. Factor VIII
    • 9.1.3. Prothrombin Complex Concentrates
    • 9.1.4. Fibrinogen Concentrates
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Immunology & Neurology
    • 9.2.2. Hematology
    • 9.2.3. Critical Care
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & Clinics
    • 9.3.2. Clinical Research Laboratories
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Coagulation Factors Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Factor IX
    • 10.1.2. Factor VIII
    • 10.1.3. Prothrombin Complex Concentrates
    • 10.1.4. Fibrinogen Concentrates
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Immunology & Neurology
    • 10.2.2. Hematology
    • 10.2.3. Critical Care
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & Clinics
    • 10.3.2. Clinical Research Laboratories
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. CSL
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Takeda Pharmaceutical Company Limited
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Kedrion S.p.A.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Octapharma AG
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. LFB
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Bayer AG
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 4: Global Coagulation Factors Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 6: North America Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 8: North America Coagulation Factors Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 10: Europe Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: Europe Coagulation Factors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Asia Pacific Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 16: Asia Pacific Coagulation Factors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 18: Latin America Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Latin America Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 20: Latin America Coagulation Factors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Coagulation Factors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Middle East & Africa Coagulation Factors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Coagulation Factors Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 24: Middle East & Africa Coagulation Factors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Coagulation Factors Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Coagulation Factors Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Coagulation Factors Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Coagulation Factors Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Coagulation Factors Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Coagulation Factors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Coagulation Factors Market Value Share (%), by Type, 2025
  • Figure 8: North America Coagulation Factors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Coagulation Factors Market Value Share (%), by Application, 2025
  • Figure 10: North America Coagulation Factors Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Coagulation Factors Market Value Share (%), by End User, 2025
  • Figure 12: North America Coagulation Factors Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Coagulation Factors Market Value Share (%), By Country, 2025
  • Figure 14: Europe Coagulation Factors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Coagulation Factors Market Value Share (%), by Type, 2025
  • Figure 16: Europe Coagulation Factors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Coagulation Factors Market Value Share (%), by Application, 2025
  • Figure 18: Europe Coagulation Factors Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Coagulation Factors Market Value Share (%), by End User, 2025
  • Figure 20: Europe Coagulation Factors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Coagulation Factors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Coagulation Factors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Coagulation Factors Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Coagulation Factors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Coagulation Factors Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Coagulation Factors Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Coagulation Factors Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Coagulation Factors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Coagulation Factors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Coagulation Factors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Coagulation Factors Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Coagulation Factors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Coagulation Factors Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Coagulation Factors Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Coagulation Factors Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Coagulation Factors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Coagulation Factors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Coagulation Factors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Coagulation Factors Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Coagulation Factors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Coagulation Factors Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Coagulation Factors Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Coagulation Factors Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Coagulation Factors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Coagulation Factors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Coagulation Factors Market Share (%), By Company, 2025